An Umbrella Review of Effectiveness of Intravenous Ketamine in Treatment-Resistant Depression

被引：0
|
作者：
Klassen, A. M. [1 ]
Baten, C. [1 ]
Shepherd, J. H. [1 ]
Zamora, G. [1 ]
Johnson-Venegas, E. [1 ]
Madugula, S. S. [2 ]
Woo, E. [1 ]
Miller, J. A. [3 ]
Sacchet, M. D. [4 ]
Hedges, D. W. [5 ]
Miller, C. H. [1 ]
机构：
[1] Calif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Palo Alto Univ, Dept Psychol, Palo Alto, CA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA
[5] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
O0099
引用
收藏
页码：S86 / S87
页数：2
相关论文
共 50 条
  • [1] Efficacy of Ketamine in Treatment-Resistant Depression: An Umbrella Review
    Klassen, Amanda M.
    Baten, Caitlin
    Zamora, Gladys
    Shepherd, Jonah H.
    Johnson-Venegas, Ellie
    Madugula, Sasidhar S.
    Woo, Ellen
    Hamilton, J. Paul
    Miller, Jennifer A.
    Sacchet, Matthew D.
    Hedges, Dawson W.
    Miller, Chris H.
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S198 - S198
  • [2] INTRAVENOUS KETAMINE FOR TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS?
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S284 - S284
  • [3] Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
    Rivas-Grajales, Ana Maria
    Salas, Ramiro
    Robinson, Meghan E.
    Qi, Karen
    Murrough, James W.
    Mathew, Sanjay J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (05): : 383 - 391
  • [4] A systematic review of ketamine for treatment-resistant depression
    Patel, Reshmee
    Loh, Feng-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 132 - 132
  • [5] Intravenous ketamine therapy in a patient with a treatment-resistant major depression
    Liebrenz, Michael
    Borgeat, Alain
    Leisinger, Ria
    Stohler, Rudolf
    SWISS MEDICAL WEEKLY, 2007, 137 (15-16) : 234 - 236
  • [6] Continuation Phase Intravenous Ketamine in Adults With Treatment-Resistant Depression
    Bobo, William
    Voort, Jennifer Vande
    Morgan, Robert
    Rico, Jose
    Ritter, Matthew
    Tye, Susannah
    Frye, Mark
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S168 - S169
  • [7] Effect of intravenous ketamine on suicidality in adults with treatment-resistant depression: A real world effectiveness study
    Chen-Li, David C. J.
    Mansur, Rodrigo B.
    Di Vincenzo, Joshua D.
    Chisamore, Noah
    Kaczmarek, Erica
    Mcintyre, Roger S.
    Rosenblat, Joshua D.
    PSYCHIATRY RESEARCH, 2025, 343
  • [8] The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
    Serafini, Gianluca
    Howland, Robert H.
    Rovedi, Fabiana
    Girardi, Paolo
    Amore, Mario
    CURRENT NEUROPHARMACOLOGY, 2014, 12 (05) : 444 - 461
  • [9] Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
    Shiroma, Paulo R.
    Albott, C. Sophia
    Johns, Brian
    Thuras, Paul
    Wels, Joseph
    Lim, Kelvin O.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (11): : 1805 - 1813
  • [10] Neural Correlates of Treatment Response to Intravenous Ketamine in Adolescents With Treatment-Resistant Depression
    Cullen, Kathryn
    Klimes-Dougan, Bonnie
    Amatya, Palistha
    Thai, Michelle
    Schreiner, Melinda Westlund
    Roback, Mark
    Albott, Sophia
    Ren, Yanan
    Eberly, Lynn
    Lim, Kelvin
    Mueller, Bryon
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S179 - S180
12345